Monitoring and managing graft health in the kidney transplant recipient

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 7, 2011, Pages 1774-1780

  Josephson, Michelle A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS;

ARTICLE; CLINICAL PROTOCOL; CLINICAL STUDY; CREATININE BLOOD LEVEL; EVIDENCE BASED PRACTICE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEALTH SURVEY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMMUNE STATUS; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; PATIENT MONITORING; PRACTICE GUIDELINE; PROTEINURIA; RENAL GRAFT DYSFUNCTION; SCREENING; SENSITIVITY AND SPECIFICITY;

EVIDENCE-BASED MEDICINE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LONG-TERM CARE; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; SURVIVORS; TIME FACTORS;

EID: 79960302391     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01230211     Document Type: Article

References (48)

1. US Department of Health and Human Services, Health Resources and Services Administration Healthcare Systems Bureau Division of Transplantation: 2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999-2008, Rockville, MD, US Department of Health and Human Services, 2010
2. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B: Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4: 378-383, 2004
3. El-Zoghby ZM, Stegall MD, Lager DJ, Norby SM, Fervenza FC, Cosio FG: Identifying specific causes of kidney allograft loss. Am J Transplant 9: 527-535, 2009
4. White CA, Huang D, Akbari A, Garland J, Knoll GA: Performance of creatinine-based estimates of GFR in kidney transplant recipients: A systematic review. Am J Kidney Dis 51: 1005-1015, 2008
5. Burke JT, Brault Y, Kahan BD, Hricik DE, Grinyó JM, Chapman JR, Polinsky M, Neylan JF: Accuracy and variability of equations to estimate glomerular filtration rates in renal transplant patients receiving sirolimus and/or calcineurin inhibitor immunosuppression. Transpl Int 21: 434-440, 2008
6. Kukla A, El-Shahawi Y, Leister E, Kasiske B, Mauer M, Matas A, Ibrahim HN: GFR-estimating models in kidney transplant recipients on a steroid-free regimen. Nephrol Dial Transplant 25: 1653-1661, 2010
7. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9[Suppl 3]: S1-S155, 2009
8. Kukla A, Adulla M, Pascual J, Samaniego M, Nanovic L, Becker BN, Djamali A: CKD stage-to-stage progression in native and transplant kidney disease. Nephrol Dial Transplant 23: 693-700, 2008
9. Kasiske BL, Israni AK, Snyder JJ, Skeans MA, Patient Outcomes in Renal Transplantation (PORT) Investigators: The Relationship between kidney function and long-term graft survival after kidney transplant. Am J Kidney Dis 57: 466-475, 2011
10. Costa de Oliveira CM, Mota MU, Mota RS, Nóbrega JO, Melo DS, Vieira AS, Fernandes PF, Campos Hde H, Evangelista JB Jr: Prevalence and staging of chronic kidney disease in renal transplant recipients. Clin Transplant 23: 628-636, 2009
11. Levey AS, de Jong PE, Coresh J, Nahas ME, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU: The definition, classification and prognosis of chronic kidney disease: A KDIGO Controversies Conference report. Kidney Int December 8, 2010 [epub ahead of print]
12. Yilmaz S, Isik I, Afrouzian M, Monroy M, Sar A, Benediktsson H, McLaughlin K: Evaluating the accuracy of functional biomarkers for detecting histological changes in chronic allograft nephropathy. Transpl Int 20: 608-615, 2007
13. Mengel M, Gwinner W, Schwarz A, Bajeski R, Franz I, Bröcker V, Becker T, Neipp M, Klempnauer J, Haller H, Kreipe H: Infiltrates in protocol biopsies from renal allografts. Am J Transplant 7: 356-365, 2007
14. Cosio FG, Grande JP, Wadei H, Larson TS, Griffin MD, Stegall MD: Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 5: 2464-2472, 2005
15. Rush D, Arlen D, Boucher A, Busque S, Cockfield SM, Girardin C, Knoll G, Lachance JG, Landsberg D, Shapiro J, Shoker A, Yilmaz S: Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: A randomized study. Am J Transplant 7: 2538-2545, 2007
16. Wavamunno MD, O'Connell PJ, Vitalone M, Fung CL, Allen RD, Chapman JR, Nankivell BJ: Transplant glomerulopathy: Ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am J Transplant 7: 2757-2768, 2007
17. Rush D: Can protocol biopsy better inform our choices in renal transplantation? Transplant Proc 41: S6-S8, 2009
18. Haas M, Montgomery RA, Segev DL, Rahman MH, Racusen LC, Bagnasco SM, Simpkins CE, Warren DS, Lepley D, Zachary AA, Kraus ES: Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts. Am J Transplant 7: 576-585, 2007
19. Kraus ES, Parekh RS, Oberai P, Lepley D, Segev DL, Bagnasco S, Collins V, Leffell M, Lucas D, Rabb H, Racusen LC, Singer AL, Stewart ZA, Warren DS, Zachary AA, Haas M, Montgomery RA: Subclinical rejection in stable positive crossmatch kidney transplant patients: Incidence and correlations. Am J Transplant 9: 1826-1834, 2009
20. Jordan SC, Vo AA, Tyan D, Nast CC, Toyoda M: Current approaches to treatment of antibody-mediated rejection. Pediatr Transplant 9: 408-415, 2005
21. Anglicheau D, Loupy A, Lefaucheur C, Pessione F, Létourneau I, Côté I, Gaha K, Noël LH, Patey N, Droz D, Martinez F, Zuber J, Glotz D, Thervet E, Legendre C: A simple clinicohistopathological composite scoring system is highly predictive of graft outcomes in marginal donors. Am J Transplant 8: 2325-2334, 2008
22. Munivenkatappa RB, Schweitzer EJ, Papadimitriou JC, Drachenberg CB, Thom KA, Perencevich EN, Haririan A, Rasetto F, Cooper M, Campos L, Barth RN, Bartlett ST, Philosophe B: The Maryland aggregate pathology index: A deceased donor kidney biopsy scoring system for predicting graft failure. Am J Transplant 8: 2316-2324, 2008
23. Mueller TF, Reeve J, Jhangri GS, Mengel M, Jacaj Z, Cairo L, Obeidat M, Todd G, Moore R, Famulski KS, Cruz J, Wishart D, Meng C, Sis B, Solez K, Kaplan B, Halloran PF: The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant 8: 78-85, 2008
24. Lin NC, Yang AH, King KL, Wu TH, Yang WC, Loong CC: Results of kidney transplantation from high-terminal creatinine donors and the role of time-zero biopsy. Transplant Proc 42: 3382-3386, 2010
25. Mengel M, Sis B: An appeal for zero-time biopsies in renal transplantation. Am J Transplant 8: 2181-2182, 2008
26. Schold JD, Rehman S, Kayle LK, Magliocca J, Srinivas TR, Meier-Kriesche HU: Treatment of BK virus: Incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl Int 22: 626-634, 2009
27. Afaneh C, Muthukumar T, Lubetzky M, Ding R, Snopkowski C, Sharma VK, Seshan S, Dadhania D, Schwartz JE, Suthanthiran M: Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts. Transplantation 90: 1381-1387, 2010
28. Dadhania D, Snopkowski C, Ding R, Muthukumar T, Lee J, Bang H, Sharma VK, Seshan S, August P, Kapur S, Suthanthiran M: Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers. Transplantation 90: 189-197, 2010
29. Hartono C, Muthukumar T, Suthanthiran M: Noninvasive diagnosis of acute rejection of renal allografts. Curr Opin Organ Transplant 15: 35-41, 2010
30. Berglund D, Bengtsson M, Biglarnia A, Berglund E, Yamamoto S, von Zur-Mühlen B, Lorant T, Tufveson G: Screening of mortality in transplant patients using an assay for immune function. Transpl Immunol January 11, 2011 [epub ahead of print]
31. Serban G, Whittaker V, Fan J, Liu Z, Manga K, Khan M, Kontogianni K, Padmanabhan A, Cohen D, Suciu-Foca N, Ratner L, Colovai AI: Significance of immune cell function monitor-ing in renal transplantation after Thymoglobulin induction therapy. Hum Immunol 70: 882-890, 2009
32. Hricik DE, Rodriguez V, Riley J, Bryan K, Tary-Lehmann M, Greenspan N, Dejelo C, Schulak JA, Heeger PS: Enzyme linked immunosorbent spot (ELISPOT) assay for interferongamma independently predicts renal function in kidney transplant recipients. Am J Transplant 3: 878-884, 2003
33. Atsumi H, Asaka M, Kimura S, Imura J, Fujimoto K, Chikazawa Y, Nakagawa M, Okuyama H, Yamaya H, Moriyama M, Tanaka T, Suzuki K, Yokoyama H: A case of second renal transplantation with acute antibody-mediated rejection complicated with BK virus nephropathy. Clin Transplant 24 Suppl 22: 35-38, 2010
34. Zeevi A, Lunz JG 3rd, Shapiro R, Randhawa P, Mazariegos G, Webber S, Girnita A: Emerging role of donor-specific antihuman leukocyte antigen antibody determination for clinical management after solid organ transplantation. Hum Immunol 70: 645-650, 2009
35. Gill JS, Landsberg D, Johnston O, Shapiro RJ, Magil AB, Wu V, Tinckam K, Keown P: Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection. Transplantation 89: 178-184, 2010
36. Amer H, Fidler ME, Myslak M, Morales P, Kremers WK, Larson TS, Stegall MD, Cosio FG: Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant 7: 2748-2756, 2007
37. Am H, Cosio FG: Significance and management of proteinuria in kidney transplant recipients. J Am Soc Nephrol 20: 2490-2492, 2009
38. Ramos E, Drachenberg CB, Wali R, Hirsch HH: The decade of polyomavirus BK-associated nephropathy: State of affairs. Transplantation 87: 621-630, 2009
39. Stallone G, Infante B, Pontrelli P, Gigante M, Montemurno E, Loverre A, Rossini M, Schena FP, Grandaliano G, Gesualdo L: Sirolimus and proteinuria in renal transplant patients: Evidence for a dose-dependent effect on slit diaphragm-associated proteins. Transplantation 2011
40. Pallet N, Legendre C: Deciphering calcineurin inhibitor nephrotoxicity: A pharmacological approach. Pharmacogenomics 11: 1491-1501, 2010
41. Marcén R, Morales JM, Fernández-Rodriguez A, Capdevila L, Pallardó L, Plaza JJ, Cubero JJ, Puig JM, Sanchez-Fructuoso A, Arias M, Alperovich G, Serón D: Long-term graft function changes in kidney transplant recipients. NDT Plus 3: ii2-ii8, 2010
42. Gill JS, Tonelli M, Mix CH, Pereira BJ: The change in allograft function among long-term kidney transplant recipients. J Am Soc Nephrol 14: 1636-1642, 2003
43. Lattanzio MR, Weir MR: Does blockade of the renin-angiotensin-aldosterone system slow progression of all forms of kidney disease? Curr Hypertens Rep 12: 369-377, 2010
44. Moreso F, Ibernon M, Gomá M, Carrera M, Fulladosa X, Hueso M, Gil-Vernet S, Cruzado JM, Torras J, Grinyó JM, Serón D: Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 6: 747-752, 2006
45. Gourishankar S, Leduc R, Connett J, Cecka JM, Cosio F, Fieberg A, Gaston R, Halloran P, Hunsicker L, Kasiske B, Rush D, Grande J, Mannon R, Matas A: Pathological and clinical characterization of the 'troubled transplant': Data from the DeKAF study. Am J Transplant 10: 324-330, 2010
46. Matas AJ, Leduc R, Rush D, Cecka JM, Connett J, Fieberg A, Halloran P, Hunsicker L, Cosio F, Grande J, Mannon R, Gourishankar S, Gaston R, Kasiske B: Histopathologic clusters differentiate subgroups within the nonspecific diagnoses of CAN or CR: Preliminary data from the DeKAF study. Am J Transplant 10: 315-323, 2010
47. Gaston RS, Cecka JM, Kasiske BL, Fieberg AM, Leduc R, Cosio FC, Gourishankar S, Grande J, Halloran P, Hunsicker L, Mannon R, Rush D, Matas AJ: Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 90: 68-74, 2010
48. Mannon RB, Matas AJ, Grande J, Leduc R, Connett J, Kasiske B, Cecka JM, Gaston RS, Cosio F, Gourishankar S, Halloran PF, Hunsicker L, Rush D, DeKAF Investigators: Inflammation in areas of tubular atrophy in kidney allograft biopsies: A potent predictor of allograft failure. Am J Transplant 10: 2066-2073, 2010